$3.13 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 76 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 51.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $191,529,000 | +21.1% | 144,832,000 | +6.5% | 6.11% | -5.2% | |
AHCO | New | ADAPTHEALTH CORP | $188,855,000 | – | 17,199,888 | +100.0% | 6.03% | – |
HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $171,672,000 | -2.4% | 4,742,311 | -26.6% | 5.48% | -23.7% |
MYL | Buy | MYLAN N V | $163,850,000 | +8.2% | 8,151,754 | +6.5% | 5.23% | -15.3% |
NEVRO CORPnote 1.750% 6/0 | $154,250,000 | +17.4% | 115,776,000 | 0.0% | 4.92% | -8.1% | ||
ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $121,856,000 | +14.9% | 8,862,247 | -0.7% | 3.89% | -10.0% |
FIXX | Sell | HOMOLOGY MEDICINES INC | $108,585,000 | +4.1% | 5,245,638 | -8.9% | 3.46% | -18.5% |
RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $98,482,000 | +76.2% | 4,289,291 | +65.7% | 3.14% | +37.9% |
MIRM | MIRUM PHARMACEUTICALS INC | $84,567,000 | +143.7% | 3,448,912 | 0.0% | 2.70% | +90.7% | |
TNDM | Buy | TANDEM DIABETES CARE INC | $81,150,000 | +202.8% | 1,361,345 | +199.6% | 2.59% | +136.9% |
XLRN | Buy | ACCELERON PHARMA INC | $72,618,000 | +40.8% | 1,369,625 | +4.9% | 2.32% | +10.2% |
RARX | Sell | RA PHARMACEUTICALS INC | $71,320,000 | +74.5% | 1,519,718 | -12.1% | 2.28% | +36.6% |
CNC | Buy | CENTENE CORP DEL | $69,685,000 | +123.6% | 1,108,400 | +53.9% | 2.22% | +74.9% |
XENT | Sell | INTERSECT ENT INC | $69,646,000 | +31.7% | 2,797,033 | -10.0% | 2.22% | +3.1% |
INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $58,256,000 | +17.6% | 57,791,000 | 0.0% | 1.86% | -7.9% | ||
MYOK | Sell | MYOKARDIA INC | $57,506,000 | +12.4% | 789,000 | -19.6% | 1.84% | -12.1% |
ARDX | Buy | ARDELYX INC | $52,567,000 | +228.9% | 7,004,253 | +106.0% | 1.68% | +157.2% |
BKD | Buy | BROOKDALE SR LIVING INC | $52,514,000 | -3.9% | 7,223,419 | +0.2% | 1.68% | -24.7% |
SILK | Buy | SILK ROAD MEDICAL INC | $51,665,000 | +62.2% | 1,279,480 | +30.6% | 1.65% | +26.9% |
DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $50,889,000 | +84.8% | 4,756,000 | +48.6% | 1.62% | +44.7% |
New | DEXCOM INCnote 0.750%12/0 | $50,441,000 | – | 34,000,000 | +100.0% | 1.61% | – | |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $49,263,000 | +138.4% | 2,164,471 | +22.0% | 1.57% | +86.5% |
VCEL | Buy | VERICEL CORP | $47,808,000 | +51.7% | 2,747,563 | +32.0% | 1.52% | +18.8% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $45,255,000 | +63.3% | 564,914 | +49.8% | 1.44% | +27.8% |
ARVN | Buy | ARVINAS INC | $44,716,000 | +125.2% | 1,088,234 | +18.1% | 1.43% | +76.4% |
CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $42,905,000 | +1.5% | 49,064,000 | 0.0% | 1.37% | -20.5% | ||
AERI | Sell | AERIE PHARMACEUTICALS INC | $42,835,000 | -51.2% | 1,772,255 | -61.2% | 1.37% | -61.8% |
FATE | Buy | FATE THERAPEUTICS INC | $39,191,000 | +29.2% | 2,002,605 | +2.5% | 1.25% | +1.1% |
SIEN | Buy | SIENTRA INC | $37,795,000 | +41.0% | 4,227,680 | +2.2% | 1.21% | +10.3% |
IMMU | Sell | IMMUNOMEDICS INC | $36,451,000 | -14.5% | 1,722,618 | -46.4% | 1.16% | -33.1% |
ALEC | ALECTOR INC | $35,783,000 | +19.5% | 2,076,812 | 0.0% | 1.14% | -6.5% | |
EDIT | EDITAS MEDICINE INC | $34,313,000 | +30.2% | 1,158,841 | 0.0% | 1.10% | +2.0% | |
SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $30,339,000 | +33.2% | 788,243 | -25.0% | 0.97% | +4.2% |
HUM | Buy | HUMANA INC | $30,055,000 | +75.5% | 82,000 | +22.4% | 0.96% | +37.4% |
BOLD | AUDENTES THERAPEUTICS INC | $29,555,000 | +113.0% | 493,901 | 0.0% | 0.94% | +66.6% | |
ARGX | Sell | ARGENX SEsponsored adr | $29,536,000 | -7.8% | 184,000 | -34.5% | 0.94% | -27.9% |
PTC THERAPEUTICS INCnote 3.000% 8/1 | $28,400,000 | +9.6% | 24,877,000 | 0.0% | 0.91% | -14.2% | ||
SRPT | Sell | SAREPTA THERAPEUTICS INC | $27,098,000 | -5.8% | 210,000 | -45.0% | 0.86% | -26.3% |
CNST | Buy | CONSTELLATION PHARMCETICLS I | $25,911,000 | +16946.7% | 550,000 | +2230.5% | 0.83% | +13683.3% |
FREQ | New | FREQUENCY THERAPEUTICS INC | $24,869,000 | – | 1,418,665 | +100.0% | 0.79% | – |
AVRO | Buy | AVROBIO INC | $23,451,000 | +232.2% | 1,164,970 | +133.0% | 0.75% | +159.7% |
AXNX | New | AXONICS MODULATION TECH INC | $23,219,000 | – | 837,945 | +100.0% | 0.74% | – |
TPTX | Sell | TURNING POINT THERAPEUTICS I | $22,798,000 | +56.5% | 366,000 | -5.6% | 0.73% | +22.4% |
CABA | New | CABALETTA BIO INC | $22,750,000 | – | 1,628,504 | +100.0% | 0.73% | – |
MRTX | Sell | MIRATI THERAPEUTICS INC | $22,422,000 | +23.5% | 174,000 | -25.3% | 0.72% | -3.4% |
BCRX | Buy | BIOCRYST PHARMACEUTICALS | $21,994,000 | +176.7% | 6,375,143 | +129.8% | 0.70% | +116.7% |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $20,443,000 | +29.2% | 100,000 | -49.2% | 0.65% | +1.1% |
MOH | Sell | MOLINA HEALTHCARE INC | $20,141,000 | -6.8% | 148,433 | -24.7% | 0.64% | -27.0% |
GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $19,952,000 | +53.4% | 251,000 | -6.4% | 0.64% | +20.2% |
EHTH | Buy | EHEALTH INC | $19,600,000 | +166.8% | 204,000 | +85.5% | 0.62% | +108.3% |
ADUS | Sell | ADDUS HOMECARE CORP | $19,241,000 | -4.0% | 197,915 | -21.7% | 0.61% | -24.8% |
DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $19,170,000 | -5.0% | 308,000 | -48.2% | 0.61% | -25.6% |
SEM | Sell | SELECT MED HLDGS CORP | $18,513,000 | -34.8% | 793,200 | -53.7% | 0.59% | -49.0% |
XERS | Buy | XERIS PHARMACEUTICALS INC | $18,212,000 | -19.7% | 2,583,291 | +11.9% | 0.58% | -37.2% |
FTSV | Sell | FORTY SEVEN INC | $17,598,000 | +265.5% | 447,000 | -40.4% | 0.56% | +186.2% |
RVNC | New | REVANCE THERAPEUTICS INC | $14,607,000 | – | 900,000 | +100.0% | 0.47% | – |
KOD | New | KODIAK SCIENCES INC | $14,390,000 | – | 200,000 | +100.0% | 0.46% | – |
MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $14,053,000 | +39.1% | 4,026,750 | -3.9% | 0.45% | +8.7% |
KIDS | New | ORTHOPEDIATRICS CORP | $10,573,000 | – | 225,000 | +100.0% | 0.34% | – |
ATRC | ATRICURE INC | $9,518,000 | +30.3% | 292,777 | 0.0% | 0.30% | +2.0% | |
SYRS | SYROS PHARMACEUTICALS INC | $8,768,000 | -33.4% | 1,268,946 | 0.0% | 0.28% | -47.9% | |
ISEE | New | IVERIC BIO INC | $8,580,000 | – | 1,000,000 | +100.0% | 0.27% | – |
TXMD | New | THERAPEUTICSMD INC COM STK | $5,445,000 | – | 2,250,000 | +100.0% | 0.17% | – |
STIM | Buy | NEURONETICS INC | $4,827,000 | +71.1% | 1,075,000 | +216.6% | 0.15% | +33.9% |
XFOR | Sell | X4 PHARMACEUTICALS INC | $4,809,000 | -32.9% | 449,437 | -20.3% | 0.15% | -47.6% |
New | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $4,632,000 | – | 3,500,000 | +100.0% | 0.15% | – | |
ITMR | ITAMAR MED LTDsponsored ads | $4,043,000 | +47.1% | 314,136 | 0.0% | 0.13% | +15.2% | |
PBYI | New | PUMA BIOTECHNOLOGY INC | $3,469,000 | – | 396,472 | +100.0% | 0.11% | – |
SWAV | New | SHOCKWAVE MED INC | $3,074,000 | – | 70,000 | +100.0% | 0.10% | – |
INGN | Sell | INOGEN INC | $2,529,000 | -72.5% | 37,016 | -80.7% | 0.08% | -78.3% |
AERI | New | AERIE PHARMACEUTICALS INCput | $2,509,000 | – | 103,800 | +100.0% | 0.08% | – |
ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $2,435,000 | – | 211,343 | +100.0% | 0.08% | – |
ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $956,000 | -40.7% | 248,992 | -38.8% | 0.03% | -53.0% |
PRTO | Buy | PROTEON THERAPEUTICS INC | $832,000 | +161.6% | 2,029,000 | +65.6% | 0.03% | +107.7% |
NEOS | NEOS THERAPEUTICS INC | $485,000 | +2.1% | 320,993 | 0.0% | 0.02% | -21.1% | |
KMPH | Sell | KEMPHARM INC | $196,000 | -58.9% | 517,692 | -25.2% | 0.01% | -68.4% |
MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -99,622 | -100.0% | -0.02% | – |
EYEN | Exit | EYENOVIA INC | $0 | – | -197,069 | -100.0% | -0.03% | – |
VRAY | Exit | VIEWRAY INC | $0 | – | -378,623 | -100.0% | -0.04% | – |
CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -92,477 | -100.0% | -0.07% | – |
AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -1,591,652 | -100.0% | -0.08% | – |
SYBX | Exit | SYNLOGIC INC | $0 | – | -1,107,643 | -100.0% | -0.10% | – |
ATEC | Exit | ALPHATEC HOLDINGS INC | $0 | – | -536,517 | -100.0% | -0.11% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -816,096 | -100.0% | -0.14% | – |
MOR | Exit | MORPHOSYS AGsponsored ads | $0 | – | -124,701 | -100.0% | -0.14% | – |
HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -264,497 | -100.0% | -0.15% | – |
IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -422,974 | -100.0% | -0.16% | – |
AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -500,046 | -100.0% | -0.16% | – |
ALIM | Exit | ALIMERA SCIENCES INC | $0 | – | -7,062,607 | -100.0% | -0.16% | – |
IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -250,000 | -100.0% | -0.18% | – |
ABMD | Exit | ABIOMED INC | $0 | – | -27,600 | -100.0% | -0.20% | – |
PRVB | Exit | PROVENTION BIO INC | $0 | – | -725,000 | -100.0% | -0.20% | – |
MDCO | Exit | MEDICINES COput | $0 | – | -100,000 | -100.0% | -0.20% | – |
Exit | TELIGENT INC NEWnote 4.750% 5/0 | $0 | – | -9,567,000 | -100.0% | -0.23% | – | |
BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -290,000 | -100.0% | -0.25% | – |
AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -339,480 | -100.0% | -0.29% | – |
GH | Exit | GUARDANT HEALTH INC | $0 | – | -126,000 | -100.0% | -0.33% | – |
KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -890,668 | -100.0% | -0.42% | – |
KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -1,274,086 | -100.0% | -0.44% | – |
AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -2,722,241 | -100.0% | -0.46% | – |
DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -2,996,328 | -100.0% | -0.60% | – |
ANAB | Exit | ANAPTYSBIO INC | $0 | – | -425,443 | -100.0% | -0.61% | – |
GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -101,010 | -100.0% | -0.63% | – |
PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -471,000 | -100.0% | -0.65% | – |
Exit | WRIGHT MED GROUP N Vnote 2.250%11/1 | $0 | – | -13,625,000 | -100.0% | -0.65% | – | |
WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -807,727 | -100.0% | -0.68% | – |
AXGN | Exit | AXOGEN INC | $0 | – | -1,842,330 | -100.0% | -0.94% | – |
DFBHU | Exit | DFB HEALTHCARE ACQUISTION COunit 01/30/2023 | $0 | – | -2,500,000 | -100.0% | -1.05% | – |
CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -1,540,305 | -100.0% | -1.27% | – |
Exit | KEMPHARM INCnote 5.500% 2/0 | $0 | – | -62,423,000 | -100.0% | -1.31% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
EHEALTH INC | 25 | Q3 2020 | 2.0% |
INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
MYLAN NV | 23 | Q3 2020 | 6.2% |
PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-19 |
4 | 2024-03-19 |
4 | 2024-03-12 |
3 | 2024-03-08 |
4 | 2024-02-16 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
3 | 2024-02-01 |
4 | 2023-11-21 |
13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.